{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,6]],"date-time":"2026-09-06T05:01:43Z","timestamp":1788670903930,"version":"build-2803163510"},"reference-count":27,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T00:00:00Z","timestamp":1761955200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T00:00:00Z","timestamp":1761955200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/100006108","name":"National Center for Advancing Translational Sciences","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100006108","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100007299","name":"Harvard University Harvard Catalyst","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100007299","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100007229","name":"Harvard University","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100007229","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000097","name":"National Center for Research Resources","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000097","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["practicalradonc.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Practical Radiation Oncology"],"published-print":{"date-parts":[[2025,11]]},"DOI":"10.1016\/j.prro.2025.03.014","type":"journal-article","created":{"date-parts":[[2025,4,29]],"date-time":"2025-04-29T11:30:04Z","timestamp":1745926204000},"page":"e519-e528","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"title":["The Efficacy and Toxicity of Hypofractionated Regional Nodal Irradiation in Breast Cancer Patients"],"prefix":"10.1016","volume":"15","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-9348-9380","authenticated-orcid":false,"given":"Daphna Y.","family":"Spiegel","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Julia","family":"Willcox","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Josephine","family":"Levey","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laura E.","family":"Dodge","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Abram","family":"Recht","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.prro.2025.03.014_bib0001","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1056\/NEJMoa1415340","article-title":"Regional nodal irradiation in early-stage breast cancer","volume":"373","author":"Whelan","year":"2015","journal-title":"N Engl J Med"},{"key":"10.1016\/j.prro.2025.03.014_bib0002","doi-asserted-by":"crossref","first-page":"1602","DOI":"10.1016\/S1470-2045(20)30472-1","article-title":"Internal mammary and medial supraclavicular lymph node chain irradiation in stage I-III breast cancer (EORTC 22922\/10925): 15-year results of a randomised, phase 3 trial","volume":"21","author":"Poortmans","year":"2020","journal-title":"Lancet Oncol"},{"key":"10.1016\/j.prro.2025.03.014_bib0003","doi-asserted-by":"crossref","DOI":"10.1158\/1538-7445.SABCS18-GS4-02","article-title":"Abstract GS4-02: Regional lymph node irradiation in early stage breast cancer: An EBCTCG meta-analysis of 13,000 women in 14 trials","volume":"79","author":"Dodwell","year":"2019","journal-title":"Cancer Res"},{"key":"10.1016\/j.prro.2025.03.014_bib0004","doi-asserted-by":"crossref","first-page":"2127","DOI":"10.1016\/S0140-6736(14)60488-8","article-title":"Effect of radiotherapy after mastectomy and axillary surgery on 10-year recurrence and 20-year breast cancer mortality: meta-analysis of individual patient data for 8135 women in 22 randomised trials","volume":"383","year":"2014","journal-title":"Lancet"},{"key":"10.1016\/j.prro.2025.03.014_bib0005","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1111\/tbj.13724","article-title":"Hypofractionated radiation treatment for breast cancer: The time is now","volume":"26","author":"Moran","year":"2020","journal-title":"Breast J"},{"key":"10.1016\/j.prro.2025.03.014_bib0006","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1016\/j.radonc.2013.12.006","article-title":"Hypofractionated regional nodal irradiation for breast cancer: examining the data and potential for future studies","volume":"110","author":"Badiyan","year":"2014","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.prro.2025.03.014_bib0007","doi-asserted-by":"crossref","first-page":"834","DOI":"10.1136\/bmj.1.5491.834","article-title":"Radiation-induced peripheral neuropathy","volume":"1","author":"Stoll","year":"1966","journal-title":"Br Med J."},{"key":"10.1016\/j.prro.2025.03.014_bib0008","doi-asserted-by":"crossref","first-page":"745","DOI":"10.1016\/S0360-3016(00)00674-X","article-title":"Timescale of evolution of late radiation injury after postoperative radiotherapy of breast cancer patients","volume":"48","author":"Johansson","year":"2000","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.prro.2025.03.014_bib0009","doi-asserted-by":"crossref","first-page":"209","DOI":"10.3109\/02841867209130761","article-title":"Cervical plexus lesions following post-operative radiation therapy of mammary carcinoma","volume":"11","author":"Westling","year":"1972","journal-title":"Acta Radiol Ther Phys Biol"},{"key":"10.1016\/j.prro.2025.03.014_bib0010","doi-asserted-by":"crossref","first-page":"E54","DOI":"10.1016\/j.ijrobp.2016.06.728","article-title":"Acute toxicity in a cohort of women receiving regional nodal irradiation in a routine clinical practice using modern treatment planning guidelines","volume":"96","author":"Bazan","year":"2016","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.prro.2025.03.014_bib0011","doi-asserted-by":"crossref","first-page":"1166","DOI":"10.1016\/j.ijrobp.2017.07.043","article-title":"Hypofractionated nodal radiation therapy for breast cancer was not associated with increased patient-reported arm or brachial plexopathy symptoms","volume":"99","author":"Leong","year":"2017","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.prro.2025.03.014_bib0012","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1016\/j.prro.2022.10.007","article-title":"Dosimetry and toxicity outcomes in patients treated with hypofractionated regional nodal irradiation for breast cancer: What is the best dose-volume limit to minimize risks of radiation pneumonitis?","volume":"13","author":"Schad","year":"2023","journal-title":"Pract Radiat Oncol"},{"key":"10.1016\/j.prro.2025.03.014_bib0013","doi-asserted-by":"crossref","first-page":"563","DOI":"10.1016\/j.ijrobp.2016.11.010","article-title":"Hypofractionated regional nodal irradiation for women with node-positive breast cancer","volume":"97","author":"Bellefqih","year":"2017","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.prro.2025.03.014_bib0014","doi-asserted-by":"crossref","first-page":"956","DOI":"10.1056\/NEJM199710023371402","article-title":"Adjuvant radiotherapy and chemotherapy in node-positive premenopausal women with breast cancer","volume":"337","author":"Ragaz","year":"1997","journal-title":"N Engl J Med"},{"key":"10.1016\/j.prro.2025.03.014_bib0015","doi-asserted-by":"crossref","first-page":"119","DOI":"10.31557\/APJCP.2020.21.1.119","article-title":"Comparison of treatment outcome between hypofractionated radiotherapy and conventional radiotherapy in postmastectomy breast cancer","volume":"21","author":"Tovanabutra","year":"2020","journal-title":"Asian Pac J Cancer Prev"},{"key":"10.1016\/j.prro.2025.03.014_bib0016","doi-asserted-by":"crossref","first-page":"352","DOI":"10.1016\/S1470-2045(18)30813-1","article-title":"Hypofractionated versus conventional fractionated postmastectomy radiotherapy for patients with high-risk breast cancer: a randomised, non-inferiority, open-label, phase 3 trial","volume":"20","author":"Wang","year":"2019","journal-title":"Lancet Oncol"},{"key":"10.1016\/j.prro.2025.03.014_bib0017","doi-asserted-by":"crossref","first-page":"1370","DOI":"10.1001\/jamaoncol.2024.2652","article-title":"Hypofractionated vs conventionally fractionated postmastectomy radiation after Implant-based reconstruction: A randomized clinical trial","volume":"10","author":"Wong","year":"2024","journal-title":"JAMA Oncol"},{"issue":"suppl 11","key":"10.1016\/j.prro.2025.03.014_bib0018","article-title":"A randomized trial of hypofractionated post-mastectomy radiation therapy (PMRT) in women with breast reconstruction (RT CHARM, Alliance A221505)","volume":"120","author":"Poppe","year":"2024","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.prro.2025.03.014_bib0019","doi-asserted-by":"crossref","first-page":"373e","DOI":"10.1097\/PRS.0000000000007636","article-title":"Evaluating the impact of immediate lymphatic reconstruction for the surgical prevention of lymphedema","volume":"147","author":"Johnson","year":"2021","journal-title":"Plast Reconstr Surg"},{"issue":"4S suppl 3","key":"10.1016\/j.prro.2025.03.014_bib0020","doi-asserted-by":"crossref","first-page":"S234","DOI":"10.1097\/SAP.0000000000001864","article-title":"Lymphedema incidence after axillary lymph node dissection: Quantifying the impact of radiation and the lymphatic microsurgical preventive healing approach","volume":"82","author":"Johnson","year":"2019","journal-title":"Ann Plast Surg"},{"key":"10.1016\/j.prro.2025.03.014_bib0021","article-title":"Moderately hypofractionated radiation therapy for breast cancer: A Brazilian cohort study","volume":"14","author":"de Siqueira","year":"2022","journal-title":"Lancet Reg Health Am"},{"key":"10.1016\/j.prro.2025.03.014_bib0022","doi-asserted-by":"crossref","first-page":"S76","DOI":"10.1016\/S0167-8140(22)02478-1","article-title":"OC-0102 DBCG phase III randomized trial of hypo- vs standard fractionated RT in 2879 pN+ breast cancer pts","volume":"170","author":"Offersen","year":"2022","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.prro.2025.03.014_bib0023","doi-asserted-by":"crossref","first-page":"S75","DOI":"10.1016\/S0167-8140(22)02477-X","article-title":"OC-0101 First results of FAST-Forward phase 3 RCT nodal substudy: 3-year normal tissue effects","volume":"170","author":"Wheatley","year":"2022","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.prro.2025.03.014_bib0024","doi-asserted-by":"crossref","first-page":"S309","DOI":"10.1016\/j.annonc.2024.08.174","article-title":"231O Locoregional hypo vs normofractionated RT in early breast cancer: 5 years results of the HypoG-01 phase III UNICANCER trial","volume":"35","author":"Rivera","year":"2024","journal-title":"Ann Oncol"},{"key":"10.1016\/j.prro.2025.03.014_bib0025","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1016\/j.radonc.2017.10.033","article-title":"Late normal tissue effects in the arm and shoulder following lymphatic radiotherapy: Results from the UK START (Standardisation of Breast Radiotherapy) trials","volume":"126","author":"Haviland","year":"2018","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.prro.2025.03.014_bib0026","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1056\/NEJMoa1415369","article-title":"Internal mammary and medial supraclavicular irradiation in breast cancer","volume":"373","author":"Poortmans","year":"2015","journal-title":"N Engl J Med"},{"key":"10.1016\/j.prro.2025.03.014_bib0027","doi-asserted-by":"crossref","first-page":"24","DOI":"10.3109\/02841860903352959","article-title":"Toxicity at three years with and without irradiation of the internal mammary and medial supraclavicular lymph node chain in stage I to III breast cancer (EORTC trial 22922\/10925)","volume":"49","author":"Matzinger","year":"2010","journal-title":"Acta Oncol"}],"container-title":["Practical Radiation Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1879850025001080?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1879850025001080?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,8]],"date-time":"2025-11-08T00:24:10Z","timestamp":1762561450000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1879850025001080"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,11]]},"references-count":27,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2025,11]]}},"alternative-id":["S1879850025001080"],"URL":"https:\/\/doi.org\/10.1016\/j.prro.2025.03.014","relation":{},"ISSN":["1879-8500"],"issn-type":[{"value":"1879-8500","type":"print"}],"subject":[],"published":{"date-parts":[[2025,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The Efficacy and Toxicity of Hypofractionated Regional Nodal Irradiation in Breast Cancer Patients","name":"articletitle","label":"Article Title"},{"value":"Practical Radiation Oncology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.prro.2025.03.014","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 American Society for Radiation Oncology. Published by Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}]}}